Immune & Thymic · Research deep dive
KPV: the cited literature
Every study referenced in the KPV monograph, with plain-language context, PubMed links to read each paper yourself, and how the compound appears in the dosing literature.
How this compound is studied
Across the dosing literature, KPV is studied at 200 mcg – 500 mcg per administration, typically once daily. The reference walkthrough below maps each citation to what it actually showed.
References covered
The C-terminal tripeptide of α-MSH exerts anti-inflammatory actions
FASEB J., 2002
The full walkthrough is for subscribers
Unlock the evidence grading, what each study actually found, how the trials dosed it, reported safety signals, open questions, and PubMed links for KPV.